Latest Breaking News On - Alivamab discovery services - Page 1 : comparemela.com

AlivaMab Discovery Services Changes Name to AlivaMab Biologics, Reflecting Its Continuing Expansion and Evolution

AlivaMab Discovery Services Changes Name to AlivaMab Biologics, Reflecting Its Continuing Expansion and Evolution
baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMatthew beaulieuMaya tanakaLarry greenAlivamab biologicsAlivamab discovery servicesChief executive officerMab biologicsAlivamab mouse

AbTherx, Inc : AbTherx Launches a Next-Generation Antibody Discovery Platform

The company brings together a proven team and novel technologies to increase efficiencies in antibody discoveryMOUNTAIN VIEW and SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / AbTherx, Inc., a privately held

Mecklenburg vorpommernBrian connPeter bramsStefan klotterJustin mikaDan rohrerDavid passmore as head of business developmentAbtherx incAlivamab discovery servicesAbtherx inc viewCommunications strategistAtlas miceBristol myers squibCatherine karaDavid passmoreBusiness development

AbTherx Launches a Next-Generation Antibody Discovery Platform

AbTherx Launches a Next-Generation Antibody Discovery Platform

Peter bramsJustin mikaAbtherx atlasBrian connDan rohrerDavid passmore as head of business developmentCommunications strategistAlivamab discovery servicesNews networkAbtherx incTherx launchesNext generation antibody discoveryBristol myers squibCatherine karaDavid passmoreBusiness development

AlivaMab Discovery Services Appoints Ankita Srivastava, PhD, as Vice

AlivaMab Discovery Services Appoints Ankita Srivastava, PhD, as Vice .

United statesAnkita srivastavaAblexi alivamabLos angelesLarry greenMaya tanakaJane seagalRoche genentechIchnos sciences biotherapeuticsBristol myers squibbAlivamab discovery servicesProtein sciencesAlivamab discovery services appoints ankita srivastavaNews networkMab discovery services appoints ankita srivastavaVice president

Ablexis Announces License Agreement with Adimab

Ablexis grants rights for Adimab to internalize select strains of the AlivaMab® Mouse platform for antibody drug discovery for its clientsSAN DIEGO (BUSINESS WIRE) Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agr.

Larry greenEric kraulandAlivamab discovery servicesAlivamab mouseChief executive officerMab mouseChief scientific officer